CD82 and cancer: Liprin-α1 is a part of β1-integrin signaling and recycling [15, 16], while CD82 modulates β1-integrin maturation and integrin-related cell adhesion in cancer cells [31–33], and is regulated by endocytosis and palmitoylation [34, 35].